<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:dc="http://purl.org/dc/elements/1.1/">
<channel>
<title>心血管高分期刊</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/rss-feed/?feed_id=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;utm_campaign=pubmed-2&amp;ff=20240215230943&amp;utm_source=Chrome&amp;fc=20230708114047&amp;utm_medium=rss&amp;v=2.18.0&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-
    <description>心血管高分期刊: Latest results from PubMed</description>
<atom:link href="https://pubmed.ncbi.nlm.nih.gov/rss-feed/?feed_id=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;utm_campaign=pubmed-2&amp;ff=20240215230943&amp;utm_source=Chrome&amp;fc=20230708114047&amp;utm_medium=rss&amp;v=2.18.0&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-" rel="self"></atom:link>
<docs>http://www.rssboard.org/rss-specification</docs>
<generator>PubMed RSS feeds (2.18.0)</generator>
<language>en</language>
<lastbuilddate>Fri, 16 Feb 2024 04:09:45 +0000</lastbuilddate>
<pubDate>Thu, 15 Feb 2024 06:00:00 -0500</pubDate>
<ttl>120</ttl>
<item>
<title>CHKB-DT: A Long Noncoding RNA Critical for Cardiovascular Health</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38359100/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240215230943&amp;v=2.18.0
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Circ Res. 2024 Feb 16;134(4):442-444. doi: 10.1161/CIRCRESAHA.124.324166. Epub 2024 Feb 15.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38359100/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240215230943&v=2.18.0">38359100</a> | DOI:<a href=https://doi.org/10.1161/CIRCRESAHA.124.324166>10.1161/CIRCRESAHA.124.324166</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38359100</guid>
<pubDate>Thu, 15 Feb 2024 06:00:00 -0500</pubDate>
<dc:creator>Michael L Kamradt</dc:creator>
<dc:creator>Catherine A Makarewich</dc:creator>
<dc:date>2024-02-15</dc:date>
<dc:source>Circulation research</dc:source>
<dc:title>CHKB-DT: A Long Noncoding RNA Critical for Cardiovascular Health</dc:title>
<dc:identifier>pmid:38359100</dc:identifier>
<dc:identifier>doi:10.1161/CIRCRESAHA.124.324166</dc:identifier>
</item>
<item>
<title>From Gut to Heart: Role of Indole-3-Propionic Acid in HFpEF</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38359099/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240215230943&amp;v=2.18.0
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Circ Res. 2024 Feb 16;134(4):390-392. doi: 10.1161/CIRCRESAHA.123.323947. Epub 2024 Feb 15.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38359099/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240215230943&v=2.18.0">38359099</a> | DOI:<a href=https://doi.org/10.1161/CIRCRESAHA.123.323947>10.1161/CIRCRESAHA.123.323947</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38359099</guid>
<pubDate>Thu, 15 Feb 2024 06:00:00 -0500</pubDate>
<dc:creator>Antonio Vacca</dc:creator>
<dc:creator>Gabriele G Schiattarella</dc:creator>
<dc:date>2024-02-15</dc:date>
<dc:source>Circulation research</dc:source>
<dc:title>From Gut to Heart: Role of Indole-3-Propionic Acid in HFpEF</dc:title>
<dc:identifier>pmid:38359099</dc:identifier>
<dc:identifier>doi:10.1161/CIRCRESAHA.123.323947</dc:identifier>
</item>
<item>
<title>Correction to: Cardiac Aging Is Promoted by Pseudohypoxia Increasing p300-Induced Glycolysis</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38359098/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240215230943&amp;v=2.18.0
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Circ Res. 2024 Feb 16;134(4):e1. doi: 10.1161/RES.0000000000000657. Epub 2024 Feb 15.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38359098/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240215230943&v=2.18.0">38359098</a> | DOI:<a href=https://doi.org/10.1161/RES.0000000000000657>10.1161/RES.0000000000000657</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38359098</guid>
<pubDate>Thu, 15 Feb 2024 06:00:00 -0500</pubDate>
<dc:date>2024-02-15</dc:date>
<dc:source>Circulation research</dc:source>
<dc:title>Correction to: Cardiac Aging Is Promoted by Pseudohypoxia Increasing p300-Induced Glycolysis</dc:title>
<dc:identifier>pmid:38359098</dc:identifier>
<dc:identifier>doi:10.1161/RES.0000000000000657</dc:identifier>
</item>
<item>
<title>Correction to: Macromolecular Complex Including MLL3, Carabin and Calcineurin Regulates Cardiac Remodeling</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38359097/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240215230943&amp;v=2.18.0
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Circ Res. 2024 Feb 16;134(4):e2. doi: 10.1161/RES.0000000000000658. Epub 2024 Feb 15.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38359097/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240215230943&v=2.18.0">38359097</a> | DOI:<a href=https://doi.org/10.1161/RES.0000000000000658>10.1161/RES.0000000000000658</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38359097</guid>
<pubDate>Thu, 15 Feb 2024 06:00:00 -0500</pubDate>
<dc:date>2024-02-15</dc:date>
<dc:source>Circulation research</dc:source>
<dc:title>Correction to: Macromolecular Complex Including MLL3, Carabin and Calcineurin Regulates Cardiac Remodeling</dc:title>
<dc:identifier>pmid:38359097</dc:identifier>
<dc:identifier>doi:10.1161/RES.0000000000000658</dc:identifier>
</item>
<item>
<title>Hypertension Related Co-Morbidities and Complications in Women of Sub-Saharan Africa: A Brief Review</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38359096/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240215230943&amp;v=2.18.0
      <description>Hypertension is the leading cause of cardiovascular disease in women, and sub-Saharan African (SSA) countries have some of the highest rates of hypertension in the world. Expanding knowledge of causes, management, and awareness of hypertension and its co-morbidities worldwide is an effective strategy to mitigate its harms, decrease morbidities and mortality, and improve individual quality of life. Hypertensive disorders of pregnancy (HDPs) are a particularly important subset of hypertension, as...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Circ Res. 2024 Feb 16;134(4):459-473. doi: 10.1161/CIRCRESAHA.123.324077. Epub 2024 Feb 15.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Hypertension is the leading cause of cardiovascular disease in women, and sub-Saharan African (SSA) countries have some of the highest rates of hypertension in the world. Expanding knowledge of causes, management, and awareness of hypertension and its co-morbidities worldwide is an effective strategy to mitigate its harms, decrease morbidities and mortality, and improve individual quality of life. Hypertensive disorders of pregnancy (HDPs) are a particularly important subset of hypertension, as pregnancy is a major stress test of the cardiovascular system and can be the first instance in which cardiovascular disease is clinically apparent. In SSA, women experience a higher incidence of HDP compared with other African regions. However, the region has yet to adopt treatment and preventative strategies for HDP. This delay stems from insufficient awareness, lack of clinical screening for hypertension, and lack of prevention programs. In this brief literature review, we will address the long-term consequences of hypertension and HDP in women. We evaluate the effects of uncontrolled hypertension in SSA by including research on heart disease, stroke, kidney disease, peripheral arterial disease, and HDP. Limitations exist in the number of studies from SSA; therefore, we will use data from countries across the globe, comparing and contrasting approaches in similar and dissimilar populations. Our review highlights an urgent need to prioritize public health, clinical, and bench research to discover cost-effective preventative and treatment strategies that will improve the lives of women living with hypertension in SSA.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38359096/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240215230943&v=2.18.0">38359096</a> | DOI:<a href=https://doi.org/10.1161/CIRCRESAHA.123.324077>10.1161/CIRCRESAHA.123.324077</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38359096</guid>
<pubDate>Thu, 15 Feb 2024 06:00:00 -0500</pubDate>
<dc:creator>Taija M Hahka</dc:creator>
<dc:creator>Rebecca A Slotkowski</dc:creator>
<dc:creator>Anum Akbar</dc:creator>
<dc:creator>Matt C VanOrmer</dc:creator>
<dc:creator>Lawrence Fred Sembajwe</dc:creator>
<dc:creator>Abdul M Ssekandi</dc:creator>
<dc:creator>Agnes Namaganda</dc:creator>
<dc:creator>Haruna Muwonge</dc:creator>
<dc:creator>Josephine N Kasolo</dc:creator>
<dc:creator>Annettee Nakimuli</dc:creator>
<dc:creator>Naome Mwesigwa</dc:creator>
<dc:creator>Jeanne A Ishimwe</dc:creator>
<dc:creator>Robert Kalyesubula</dc:creator>
<dc:creator>Annet Kirabo</dc:creator>
<dc:creator>Ann L Anderson Berry</dc:creator>
<dc:creator>Kaushik P Patel</dc:creator>
<dc:date>2024-02-15</dc:date>
<dc:source>Circulation research</dc:source>
<dc:title>Hypertension Related Co-Morbidities and Complications in Women of Sub-Saharan Africa: A Brief Review</dc:title>
<dc:identifier>pmid:38359096</dc:identifier>
<dc:identifier>doi:10.1161/CIRCRESAHA.123.324077</dc:identifier>
</item>
<item>
<title>Meet the First Authors</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38359094/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240215230943&amp;v=2.18.0
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Circ Res. 2024 Feb 16;134(4):344-345. doi: 10.1161/RES.0000000000000662. Epub 2024 Feb 15.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38359094/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240215230943&v=2.18.0">38359094</a> | DOI:<a href=https://doi.org/10.1161/RES.0000000000000662>10.1161/RES.0000000000000662</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38359094</guid>
<pubDate>Thu, 15 Feb 2024 06:00:00 -0500</pubDate>
<dc:date>2024-02-15</dc:date>
<dc:source>Circulation research</dc:source>
<dc:title>Meet the First Authors</dc:title>
<dc:identifier>pmid:38359094</dc:identifier>
<dc:identifier>doi:10.1161/RES.0000000000000662</dc:identifier>
</item>
<item>
<title>TR(i)P Goes On: Auxiliary TRP Channel Subunits?</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38359093/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240215230943&amp;v=2.18.0
      <description>Transient receptor potential (TRP) cation channels are a diverse family of channels whose members play prominent roles as cellular sensors and effectors. The important role of TRP channels (and mechanosensitive piezo channels) in the complex interaction of our senses with the environment was underlined by the award of the Nobel Prize in Physiology or Medicine to 2 pioneers in this field, David Julius and Ardem Patapoutian. There are many competent and comprehensive reviews on many aspects of the...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Circ Res. 2024 Feb 16;134(4):346-350. doi: 10.1161/CIRCRESAHA.123.323178. Epub 2024 Feb 15.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Transient receptor potential (TRP) cation channels are a diverse family of channels whose members play prominent roles as cellular sensors and effectors. The important role of TRP channels (and mechanosensitive piezo channels) in the complex interaction of our senses with the environment was underlined by the award of the Nobel Prize in Physiology or Medicine to 2 pioneers in this field, David Julius and Ardem Patapoutian. There are many competent and comprehensive reviews on many aspects of the TRP channels, and there is no intention to expand on them. Rather, after an introduction to the nomenclature, the molecular architecture of native TRP channel/protein complexes in vivo will be summarized using TRP channels of the canonical transient receptor potential subfamily as an example. This molecular architecture provides the basis for the signatures of native canonical transient receptor potential currents and their control by endogenous modulators and potential drugs.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38359093/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240215230943&v=2.18.0">38359093</a> | DOI:<a href=https://doi.org/10.1161/CIRCRESAHA.123.323178>10.1161/CIRCRESAHA.123.323178</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38359093</guid>
<pubDate>Thu, 15 Feb 2024 06:00:00 -0500</pubDate>
<dc:creator>Veit Flockerzi</dc:creator>
<dc:creator>Bernd Fakler</dc:creator>
<dc:date>2024-02-15</dc:date>
<dc:source>Circulation research</dc:source>
<dc:title>TR(i)P Goes On: Auxiliary TRP Channel Subunits?</dc:title>
<dc:identifier>pmid:38359093</dc:identifier>
<dc:identifier>doi:10.1161/CIRCRESAHA.123.323178</dc:identifier>
</item>
<item>
<title>Application of New Lineage Tracing Techniques in Cardiovascular Development and Physiology</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38359092/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240215230943&amp;v=2.18.0
      <description>Cardiovascular disease has been the leading cause of mortality and morbidity worldwide in the past 3 decades. Multiple cell lineages undergo dynamic alternations in gene expression, cell state determination, and cell fate conversion to contribute, adapt, and even modulate the pathophysiological processes during disease progression. There is an urgent need to understand the intricate cellular and molecular underpinnings of cardiovascular cell development in homeostasis and pathogenesis. Recent...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Circ Res. 2024 Feb 16;134(4):445-458. doi: 10.1161/CIRCRESAHA.123.323179. Epub 2024 Feb 15.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Cardiovascular disease has been the leading cause of mortality and morbidity worldwide in the past 3 decades. Multiple cell lineages undergo dynamic alternations in gene expression, cell state determination, and cell fate conversion to contribute, adapt, and even modulate the pathophysiological processes during disease progression. There is an urgent need to understand the intricate cellular and molecular underpinnings of cardiovascular cell development in homeostasis and pathogenesis. Recent strides in lineage tracing methodologies have revolutionized our understanding of cardiovascular biology with the identification of new cellular origins, fates, plasticity, and heterogeneity within the cardiomyocyte, endothelial, and mesenchymal cell populations. In this review, we introduce the new technologies for lineage tracing of cardiovascular cells and summarize their applications in studying cardiovascular development, diseases, repair, and regeneration.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38359092/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240215230943&v=2.18.0">38359092</a> | DOI:<a href=https://doi.org/10.1161/CIRCRESAHA.123.323179>10.1161/CIRCRESAHA.123.323179</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38359092</guid>
<pubDate>Thu, 15 Feb 2024 06:00:00 -0500</pubDate>
<dc:creator>MingJun Zhang</dc:creator>
<dc:creator>Kathy O Lui</dc:creator>
<dc:creator>Bin Zhou</dc:creator>
<dc:date>2024-02-15</dc:date>
<dc:source>Circulation research</dc:source>
<dc:title>Application of New Lineage Tracing Techniques in Cardiovascular Development and Physiology</dc:title>
<dc:identifier>pmid:38359092</dc:identifier>
<dc:identifier>doi:10.1161/CIRCRESAHA.123.323179</dc:identifier>
</item>
<item>
<title>Directed Differentiation of Human Induced Pluripotent Stem Cells to Heart Valve Cells</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38357822/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240215230943&amp;v=2.18.0
      <description>CONCLUSIONS: In summary, this is the first study to report an efficient strategy to generate functional hiPSC-derived valve endothelial-like cells and hiPSC-derived valve interstitial-like cells from hiPSCs, as well as to elucidate the differentiation trajectory and transcriptional dynamics of hiPSCs differentiated into heart valve cells.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2024 Feb 15. doi: 10.1161/CIRCULATIONAHA.123.065143. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: A main obstacle in current valvular heart disease research is the lack of high-quality homogeneous functional heart valve cells. Human induced pluripotent stem cells (hiPSCs)-derived heart valve cells may help with this dilemma. However, there are no well-established protocols to induce hiPSCs to differentiate into functional heart valve cells, and the networks that mediate the differentiation have not been fully elucidated.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: To generate heart valve cells from hiPSCs, we sequentially activated the Wnt, BMP4, VEGF (vascular endothelial growth factor), and NFATc1 signaling pathways using CHIR-99021, BMP4, VEGF-165, and forskolin, respectively. The transcriptional and functional similarity of hiPSC-derived heart valve cells compared with primary heart valve cells were characterized. Longitudinal single-cell RNA sequencing was used to uncover the trajectory, switch genes, pathways, and transcription factors of the differentiation.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: An efficient protocol was developed to induce hiPSCs to differentiate into functional hiPSC-derived valve endothelial-like cells and hiPSC-derived valve interstitial-like cells. After 6-day differentiation and CD144 magnetic bead sorting, ≈70% CD144<sup>+</sup> cells and 30% CD144<sup>-</sup> cells were obtained. On the basis of single-cell RNA sequencing data, the CD144<sup>+</sup> cells and CD144<sup>-</sup> cells were found to be highly similar to primary heart valve endothelial cells and primary heart valve interstitial cells in gene expression profile. Furthermore, CD144<sup>+</sup> cells had the typical function of primary heart valve endothelial cells, including tube formation, uptake of low-density lipoprotein, generation of endothelial nitric oxide synthase, and response to shear stress. Meanwhile, CD144<sup>-</sup> cells could secret collagen and matrix metalloproteinases, and differentiate into osteogenic or adipogenic lineages like primary heart valve interstitial cells. Therefore, we identified CD144<sup>+</sup> cells and CD144<sup>-</sup> cells as hiPSC-derived valve endothelial-like cells and hiPSC-derived valve interstitial-like cells, respectively. Using single-cell RNA sequencing analysis, we demonstrated that the trajectory of heart valve cell differentiation was consistent with embryonic valve development. We identified the main switch genes (NOTCH1, HEY1, and MEF2C), signaling pathways (TGF-β, Wnt, and NOTCH), and transcription factors (MSX1, SP5, and MECOM) that mediated the differentiation. Finally, we found that hiPSC-derived valve interstitial-like cells might derive from hiPSC-derived valve endothelial-like cells undergoing endocardial-mesenchymal transition.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: In summary, this is the first study to report an efficient strategy to generate functional hiPSC-derived valve endothelial-like cells and hiPSC-derived valve interstitial-like cells from hiPSCs, as well as to elucidate the differentiation trajectory and transcriptional dynamics of hiPSCs differentiated into heart valve cells.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38357822/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240215230943&v=2.18.0">38357822</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.123.065143>10.1161/CIRCULATIONAHA.123.065143</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38357822</guid>
<pubDate>Thu, 15 Feb 2024 06:00:00 -0500</pubDate>
<dc:creator>Ziwen Cai</dc:creator>
<dc:creator>Miaomiao Zhu</dc:creator>
<dc:creator>Li Xu</dc:creator>
<dc:creator>Yue Wang</dc:creator>
<dc:creator>Yin Xu</dc:creator>
<dc:creator>Wai Yen Yim</dc:creator>
<dc:creator>Hong Cao</dc:creator>
<dc:creator>Ruikang Guo</dc:creator>
<dc:creator>Xiang Qiu</dc:creator>
<dc:creator>Ximiao He</dc:creator>
<dc:creator>Jiawei Shi</dc:creator>
<dc:creator>Weihua Qiao</dc:creator>
<dc:creator>Nianguo Dong</dc:creator>
<dc:date>2024-02-15</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Directed Differentiation of Human Induced Pluripotent Stem Cells to Heart Valve Cells</dc:title>
<dc:identifier>pmid:38357822</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.123.065143</dc:identifier>
</item>
<item>
<title>S-Nitrosylation of Septin2 Exacerbates Aortic Aneurysm and Dissection by Coupling the TIAM1-RAC1 Axis in Macrophages</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38357802/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240215230943&amp;v=2.18.0
      <description>CONCLUSIONS: SNO-Septin2 drives aortic aneurysm and dissection through coupling the TIAM1-RAC1 axis in macrophages and activating the nuclear factor-κB signaling pathway-dependent inflammation and extracellular matrix degradation. Pharmacological blockade of RAC1 by R-Ketorolac or NSC23766 may therefore represent a potential treatment against aortic aneurysm and dissection.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2024 Feb 15. doi: 10.1161/CIRCULATIONAHA.123.066404. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: S-Nitrosylation (SNO), a prototypic redox-based posttranslational modification, is involved in cardiovascular disease. Aortic aneurysm and dissection are high-risk cardiovascular diseases without an effective cure. The aim of this study was to determine the role of SNO of Septin2 in macrophages in aortic aneurysm and dissection.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: Biotin-switch assay combined with liquid chromatography-tandem mass spectrometry was performed to identify the S-nitrosylated proteins in aortic tissue from both patients undergoing surgery for aortic dissection and <i>Apoe</i><sup><i>-/-</i></sup> mice infused with angiotensin II. Angiotensin II-induced aortic aneurysm model and β-aminopropionitrile-induced aortic aneurysm and dissection model were used to determine the role of SNO of Septin2 (SNO-Septin2) in aortic aneurysm and dissection development. RNA-sequencing analysis was performed to recapitulate possible changes in the transcriptome profile of SNO-Septin2 in macrophages in aortic aneurysm and dissection. Liquid chromatography-tandem mass spectrometry and coimmunoprecipitation were used to uncover the TIAM1-RAC1 (Ras-related C3 botulinum toxin substrate 1) axis as the downstream target of SNO-Septin2. Both R-Ketorolac and NSC23766 treatments were used to inhibit the TIAM1-RAC1 axis.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: Septin2 was identified S-nitrosylated at cysteine 111 (Cys111) in both aortic tissue from patients undergoing surgery for aortic dissection and <i>Apoe</i><sup><i>-/-</i></sup> mice infused with Angiotensin II. SNO-Septin2 was demonstrated driving the development of aortic aneurysm and dissection. By RNA-sequencing, SNO-Septin2 in macrophages was demonstrated to exacerbate vascular inflammation and extracellular matrix degradation in aortic aneurysm. Next, TIAM1 (T lymphoma invasion and metastasis-inducing protein 1) was identified as a SNO-Septin2 target protein. Mechanistically, compared with unmodified Septin2, SNO-Septin2 reduced its interaction with TIAM1 and activated the TIAM1-RAC1 axis and consequent nuclear factor-κB signaling pathway, resulting in stronger inflammation and extracellular matrix degradation mediated by macrophages. Consistently, both R-Ketorolac and NSC23766 treatments protected against aortic aneurysm and dissection by inhibiting the TIAM1-RAC1 axis.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: SNO-Septin2 drives aortic aneurysm and dissection through coupling the TIAM1-RAC1 axis in macrophages and activating the nuclear factor-κB signaling pathway-dependent inflammation and extracellular matrix degradation. Pharmacological blockade of RAC1 by R-Ketorolac or NSC23766 may therefore represent a potential treatment against aortic aneurysm and dissection.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38357802/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240215230943&v=2.18.0">38357802</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.123.066404>10.1161/CIRCULATIONAHA.123.066404</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38357802</guid>
<pubDate>Thu, 15 Feb 2024 06:00:00 -0500</pubDate>
<dc:creator>Yan Zhang</dc:creator>
<dc:creator>Hao Zhang</dc:creator>
<dc:creator>Shuang Zhao</dc:creator>
<dc:creator>Zhenhua Qi</dc:creator>
<dc:creator>Yiwei He</dc:creator>
<dc:creator>Xuhong Zhang</dc:creator>
<dc:creator>Wencheng Wu</dc:creator>
<dc:creator>Ke Yan</dc:creator>
<dc:creator>Lulu Hu</dc:creator>
<dc:creator>Shixiu Sun</dc:creator>
<dc:creator>Xinlong Tang</dc:creator>
<dc:creator>Qing Zhou</dc:creator>
<dc:creator>Feng Chen</dc:creator>
<dc:creator>Aihua Gu</dc:creator>
<dc:creator>Liansheng Wang</dc:creator>
<dc:creator>Zhiren Zhang</dc:creator>
<dc:creator>Bo Yu</dc:creator>
<dc:creator>Dongjin Wang</dc:creator>
<dc:creator>Yi Han</dc:creator>
<dc:creator>Liping Xie</dc:creator>
<dc:creator>Yong Ji</dc:creator>
<dc:date>2024-02-15</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>S-Nitrosylation of Septin2 Exacerbates Aortic Aneurysm and Dissection by Coupling the TIAM1-RAC1 Axis in Macrophages</dc:title>
<dc:identifier>pmid:38357802</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.123.066404</dc:identifier>
</item>
<item>
<title>Clonal Hematopoiesis of Indeterminate Potential With Loss of &lt;em>;Tet2&lt;/em>; Enhances Risk for Atrial Fibrillation Through &lt;em>;Nlrp3&lt;/em>; Inflammasome Activation</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38357791/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240215230943&amp;v=2.18.0
      <description>CONCLUSIONS: We identified a modest association between CHIP, particularly TET2 CHIP, and incident AF in the UK Biobank population. In a mouse model of AF resulting from hematopoietic-specific inactivation of Tet2, we propose altered calcium handling as an arrhythmogenic mechanism, dependent on Nlrp3 inflammasome activation. Our data are in keeping with previous studies of CHIP in cardiovascular disease, and further studies into the therapeutic potential of NLRP3 inhibition for individuals with...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2024 Feb 15. doi: 10.1161/CIRCULATIONAHA.123.065597. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: Clonal hematopoiesis of indeterminate potential (CHIP), a common age-associated phenomenon, associates with increased risk of both hematological malignancy and cardiovascular disease. Although CHIP is known to increase the risk of myocardial infarction and heart failure, the influence of CHIP in cardiac arrhythmias, such as atrial fibrillation (AF), is less explored.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: CHIP prevalence was determined in the UK Biobank, and incident AF analysis was stratified by CHIP status and clone size using Cox proportional hazard models. Lethally irradiated mice were transplanted with hematopoietic-specific loss of <i>Tet2</i>, hematopoietic-specific loss of <i>Tet2</i> and <i>Nlrp3</i>, or wild-type control and fed a Western diet, compounded with or without NLRP3 (NLR [NACHT, LRR {leucine rich repeat}] family pyrin domain containing protein 3) inhibitor, NP3-361, for 6 to 9 weeks. Mice underwent in vivo invasive electrophysiology studies and ex vivo optical mapping. Cardiomyocytes from <i>Ldlr</i><sup>-/-</sup> mice with hematopoietic-specific loss of <i>Tet2</i> or wild-type control and fed a Western diet were isolated to evaluate calcium signaling dynamics and analysis. Cocultures of pluripotent stem cell-derived atrial cardiomyocytes were incubated with <i>Tet2</i>-deficient bone marrow-derived macrophages, wild-type control, or cytokines IL-1β (interleukin 1β) or IL-6 (interleukin 6).</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: Analysis of the UK Biobank showed individuals with CHIP, in particular <i>TET2</i> CHIP, have increased incident AF. Hematopoietic-specific inactivation of <i>Tet2</i> increases AF propensity in atherogenic and nonatherogenic mouse models and is associated with increased Nlrp3 expression and CaMKII (Ca2+/calmodulin-dependent protein kinase II) activation, with AF susceptibility prevented by inactivation of <i>Nlrp3</i>. Cardiomyocytes isolated from <i>Ldlr</i><sup>-/-</sup> mice with hematopoietic inactivation of <i>Tet2</i> and fed a Western diet have impaired calcium release from the sarcoplasmic reticulum into the cytosol, contributing to atria arrhythmogenesis. Abnormal sarcoplasmic reticulum calcium release was recapitulated in cocultures of cardiomyocytes with the addition of <i>Tet2</i>-deficient macrophages or cytokines IL-1β or IL-6.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: We identified a modest association between CHIP, particularly <i>TET2</i> CHIP, and incident AF in the UK Biobank population. In a mouse model of AF resulting from hematopoietic-specific inactivation of <i>Tet2</i>, we propose altered calcium handling as an arrhythmogenic mechanism, dependent on <i>Nlrp3</i> inflammasome activation. Our data are in keeping with previous studies of CHIP in cardiovascular disease, and further studies into the therapeutic potential of NLRP3 inhibition for individuals with <i>TET2</i> CHIP may be warranted.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38357791/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240215230943&v=2.18.0">38357791</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.123.065597>10.1161/CIRCULATIONAHA.123.065597</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38357791</guid>
<pubDate>Thu, 15 Feb 2024 06:00:00 -0500</pubDate>
<dc:creator>Amy Erica Lin</dc:creator>
<dc:creator>Aneesh C Bapat</dc:creator>
<dc:creator>Ling Xiao</dc:creator>
<dc:creator>Abhishek Niroula</dc:creator>
<dc:creator>Jianchuan Ye</dc:creator>
<dc:creator>Waihay J Wong</dc:creator>
<dc:creator>Mridul Agrawal</dc:creator>
<dc:creator>Christopher J Farady</dc:creator>
<dc:creator>Andreas Boettcher</dc:creator>
<dc:creator>Christopher B Hergott</dc:creator>
<dc:creator>Marie McConkey</dc:creator>
<dc:creator>Patricio Flores-Bringas</dc:creator>
<dc:creator>Veronica Shkolnik</dc:creator>
<dc:creator>Alexander G Bick</dc:creator>
<dc:creator>David Milan</dc:creator>
<dc:creator>Pradeep Natarajan</dc:creator>
<dc:creator>Peter Libby</dc:creator>
<dc:creator>Patrick T Ellinor</dc:creator>
<dc:creator>Benjamin L Ebert</dc:creator>
<dc:date>2024-02-15</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Clonal Hematopoiesis of Indeterminate Potential With Loss of &lt;em>;Tet2&lt;/em>; Enhances Risk for Atrial Fibrillation Through &lt;em>;Nlrp3&lt;/em>; Inflammasome Activation</dc:title>
<dc:identifier>pmid:38357791</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.123.065597</dc:identifier>
</item>
<item>
<title>Reply: miRNAs, Endothelin-1 and Endothelial Glycocalyx Disorders in Shock Severity in Postoperative Cardiac Surgery Patients</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38355252/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240215230943&amp;v=2.18.0
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">J Am Coll Cardiol. 2024 Feb 20;83(7):e73. doi: 10.1016/j.jacc.2023.12.007.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38355252/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240215230943&v=2.18.0">38355252</a> | DOI:<a href=https://doi.org/10.1016/j.jacc.2023.12.007>10.1016/j.jacc.2023.12.007</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38355252</guid>
<pubDate>Wed, 14 Feb 2024 06:00:00 -0500</pubDate>
<dc:creator>Tobias Roeschl</dc:creator>
<dc:creator>Volkmar Falk</dc:creator>
<dc:creator>Felix Schoenrath</dc:creator>
<dc:creator>Alexander Meyer</dc:creator>
<dc:date>2024-02-14</dc:date>
<dc:source>Journal of the American College of Cardiology</dc:source>
<dc:title>Reply: miRNAs, Endothelin-1 and Endothelial Glycocalyx Disorders in Shock Severity in Postoperative Cardiac Surgery Patients</dc:title>
<dc:identifier>pmid:38355252</dc:identifier>
<dc:identifier>doi:10.1016/j.jacc.2023.12.007</dc:identifier>
</item>
<item>
<title>miRNAs, Endothelin-1 and Endothelial Glycocalyx Disorders in Shock Severity in Postoperative Cardiac Surgery Patients</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38355251/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240215230943&amp;v=2.18.0
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">J Am Coll Cardiol. 2024 Feb 20;83(7):e71. doi: 10.1016/j.jacc.2023.11.034.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38355251/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240215230943&v=2.18.0">38355251</a> | DOI:<a href=https://doi.org/10.1016/j.jacc.2023.11.034>10.1016/j.jacc.2023.11.034</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38355251</guid>
<pubDate>Wed, 14 Feb 2024 06:00:00 -0500</pubDate>
<dc:creator>Salvatore Patanè</dc:creator>
<dc:creator>Roberto Licordari</dc:creator>
<dc:creator>Pietro Venuto</dc:creator>
<dc:date>2024-02-14</dc:date>
<dc:source>Journal of the American College of Cardiology</dc:source>
<dc:title>miRNAs, Endothelin-1 and Endothelial Glycocalyx Disorders in Shock Severity in Postoperative Cardiac Surgery Patients</dc:title>
<dc:identifier>pmid:38355251</dc:identifier>
<dc:identifier>doi:10.1016/j.jacc.2023.11.034</dc:identifier>
</item>
<item>
<title>Reply: &lt;sup>;18&lt;/sup>;F-Flurpiridaz Myocardial Perfusion PET, What Is it That Matters? Diagnostic or Prognostic Accuracy?</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38355250/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240215230943&amp;v=2.18.0
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">J Am Coll Cardiol. 2024 Feb 20;83(7):e69. doi: 10.1016/j.jacc.2023.12.009.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38355250/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240215230943&v=2.18.0">38355250</a> | DOI:<a href=https://doi.org/10.1016/j.jacc.2023.12.009>10.1016/j.jacc.2023.12.009</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38355250</guid>
<pubDate>Wed, 14 Feb 2024 06:00:00 -0500</pubDate>
<dc:creator>Jamshid Maddahi</dc:creator>
<dc:date>2024-02-14</dc:date>
<dc:source>Journal of the American College of Cardiology</dc:source>
<dc:title>Reply: &lt;sup>;18&lt;/sup>;F-Flurpiridaz Myocardial Perfusion PET, What Is it That Matters? Diagnostic or Prognostic Accuracy?</dc:title>
<dc:identifier>pmid:38355250</dc:identifier>
<dc:identifier>doi:10.1016/j.jacc.2023.12.009</dc:identifier>
</item>
<item>
<title>&lt;sup>;18&lt;/sup>;F-Flurpiridaz Myocardial Perfusion PET, What Is it That Matters? Diagnostic or Prognostic Accuracy?</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38355249/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240215230943&amp;v=2.18.0
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">J Am Coll Cardiol. 2024 Feb 20;83(7):e67. doi: 10.1016/j.jacc.2023.10.053.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38355249/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240215230943&v=2.18.0">38355249</a> | DOI:<a href=https://doi.org/10.1016/j.jacc.2023.10.053>10.1016/j.jacc.2023.10.053</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38355249</guid>
<pubDate>Wed, 14 Feb 2024 06:00:00 -0500</pubDate>
<dc:creator>Federico Caobelli</dc:creator>
<dc:date>2024-02-14</dc:date>
<dc:source>Journal of the American College of Cardiology</dc:source>
<dc:title>&lt;sup>;18&lt;/sup>;F-Flurpiridaz Myocardial Perfusion PET, What Is it That Matters? Diagnostic or Prognostic Accuracy?</dc:title>
<dc:identifier>pmid:38355249</dc:identifier>
<dc:identifier>doi:10.1016/j.jacc.2023.10.053</dc:identifier>
</item>
<item>
<title>Participation in Competitive Sports by Patients With Congenital Heart Disease: AHA/ACC and EAPC/ESC/AEPC Guidelines Comparison</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38355248/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240215230943&amp;v=2.18.0
      <description>Sports participation in patients with congenital heart disease is an evolving subject. The American Heart Association/American College of Cardiology released a set of guidelines that advise the type and level of sports participation based primarily on anatomical defects with secondary consideration given to hemodynamic effects. Recently, the European Association of Preventive Cardiology/European Society of Cardiology/Association for European Paediatric and Congenital Cardiology offered a...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">J Am Coll Cardiol. 2024 Feb 20;83(7):772-782. doi: 10.1016/j.jacc.2023.10.037.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Sports participation in patients with congenital heart disease is an evolving subject. The American Heart Association/American College of Cardiology released a set of guidelines that advise the type and level of sports participation based primarily on anatomical defects with secondary consideration given to hemodynamic effects. Recently, the European Association of Preventive Cardiology/European Society of Cardiology/Association for European Paediatric and Congenital Cardiology offered a contrasting approach to sports participation that is based on hemodynamic and electrophysiological profiles of each patient, regardless of anatomical consideration. These guidelines are drastically different in their approaches but do have some similarities. In this review, we compare both documents, focusing on the aim, population, classification of sports, and the methodology of making recommendations. This review aims to assist practicing cardiologists in integrating the available published data and recommendations when counseling patients for sports participation.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38355248/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240215230943&v=2.18.0">38355248</a> | DOI:<a href=https://doi.org/10.1016/j.jacc.2023.10.037>10.1016/j.jacc.2023.10.037</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38355248</guid>
<pubDate>Wed, 14 Feb 2024 06:00:00 -0500</pubDate>
<dc:creator>Kamel Shibbani</dc:creator>
<dc:creator>Ali Abdulkarim</dc:creator>
<dc:creator>Werner Budts</dc:creator>
<dc:creator>Jolien Roos-Hesselink</dc:creator>
<dc:creator>Jan Müller</dc:creator>
<dc:creator>Keri Shafer</dc:creator>
<dc:creator>Prashob Porayette</dc:creator>
<dc:creator>Ali Zaidi</dc:creator>
<dc:creator>Jacqueline Kreutzer</dc:creator>
<dc:creator>Tarek Alsaied</dc:creator>
<dc:date>2024-02-14</dc:date>
<dc:source>Journal of the American College of Cardiology</dc:source>
<dc:title>Participation in Competitive Sports by Patients With Congenital Heart Disease: AHA/ACC and EAPC/ESC/AEPC Guidelines Comparison</dc:title>
<dc:identifier>pmid:38355248</dc:identifier>
<dc:identifier>doi:10.1016/j.jacc.2023.10.037</dc:identifier>
</item>
<item>
<title>Differences in Circulating Progenitor Cells and Risk of Atherosclerotic Cardiovascular Disease in South Asian Individuals</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38355247/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240215230943&amp;v=2.18.0
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">J Am Coll Cardiol. 2024 Feb 20;83(7):770-771. doi: 10.1016/j.jacc.2023.12.020.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38355247/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240215230943&v=2.18.0">38355247</a> | DOI:<a href=https://doi.org/10.1016/j.jacc.2023.12.020>10.1016/j.jacc.2023.12.020</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38355247</guid>
<pubDate>Wed, 14 Feb 2024 06:00:00 -0500</pubDate>
<dc:creator>Pradeep Natarajan</dc:creator>
<dc:creator>Aniruddh P Patel</dc:creator>
<dc:date>2024-02-14</dc:date>
<dc:source>Journal of the American College of Cardiology</dc:source>
<dc:title>Differences in Circulating Progenitor Cells and Risk of Atherosclerotic Cardiovascular Disease in South Asian Individuals</dc:title>
<dc:identifier>pmid:38355247</dc:identifier>
<dc:identifier>doi:10.1016/j.jacc.2023.12.020</dc:identifier>
</item>
<item>
<title>Vascular Regenerative Cell Deficiencies in South Asian Adults</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38355246/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240215230943&amp;v=2.18.0
      <description>CONCLUSIONS: South Asian people with cardiometabolic disease had less vascular regenerative and reparative cells suggesting compromised vessel repair capabilities that may contribute to the excess vascular risk in this population. (The Role of South Asian vs European Origins on Circulating Regenerative Cell Exhaustion [ORIGINS-RCE]; NCT05253521).</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">J Am Coll Cardiol. 2024 Feb 20;83(7):755-769. doi: 10.1016/j.jacc.2023.12.012.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: South Asian individuals shoulder a disproportionate burden of cardiometabolic diseases.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">OBJECTIVES: The purpose of this study was to determine if vascular regenerative cell content varies significantly between South Asian and White European people.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: Between January 2022 and January 2023, 60 South Asian and 60 White European adults with either documented cardiovascular disease or established diabetes with ≥1 other cardiovascular risk factor were prospectively enrolled. Vascular regenerative cell content in venous blood was enumerated using a flow cytometry assay that is based on high aldehyde dehydrogenase (ALDH<sup>hi</sup>) activity and cell surface marker phenotyping. The primary outcome was the difference in frequency of circulating ALDH<sup>hi</sup> progenitor cells, monocytes, and granulocytes between the 2 groups.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: Compared with White European participants, those of South Asian ethnicity were younger (69 ± 10 years vs 66 ± 9 years; P &lt; 0.05), had lower weight (88 ± 19 kg vs 75 ± 13 kg; P &lt; 0.001), and exhibited a greater prevalence of type 2 diabetes (62% vs 92%). South Asian individuals had markedly lower circulating frequencies of pro-angiogenic ALDH<sup>hi</sup>SSC<sup>low</sup>CD133<sup>+</sup> progenitor cells (P &lt; 0.001) and ALDH<sup>hi</sup>SSC<sup>mid</sup>CD14<sup>+</sup>CD163<sup>+</sup> monocytes with vessel-reparative capacity (P &lt; 0.001), as well as proportionally more ALDH<sup>hi</sup> progenitor cells with high reactive oxygen species content (P &lt; 0.05). After correction for sex, age, body mass index, and glycated hemoglobin, South Asian ethnicity was independently associated with lower ALDH<sup>hi</sup>SSC<sup>low</sup>CD133<sup>+</sup> cell count.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: South Asian people with cardiometabolic disease had less vascular regenerative and reparative cells suggesting compromised vessel repair capabilities that may contribute to the excess vascular risk in this population. (The Role of South Asian vs European Origins on Circulating Regenerative Cell Exhaustion [ORIGINS-RCE]; NCT05253521).</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38355246/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240215230943&v=2.18.0">38355246</a> | DOI:<a href=https://doi.org/10.1016/j.jacc.2023.12.012>10.1016/j.jacc.2023.12.012</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38355246</guid>
<pubDate>Wed, 14 Feb 2024 06:00:00 -0500</pubDate>
<dc:creator>Aishwarya Krishnaraj</dc:creator>
<dc:creator>Ehab Bakbak</dc:creator>
<dc:creator>Hwee Teoh</dc:creator>
<dc:creator>Yi Pan</dc:creator>
<dc:creator>Irene N Firoz</dc:creator>
<dc:creator>Arjun K Pandey</dc:creator>
<dc:creator>Daniella C Terenzi</dc:creator>
<dc:creator>Raj Verma</dc:creator>
<dc:creator>Basel Bari</dc:creator>
<dc:creator>Asaad I Bakbak</dc:creator>
<dc:creator>Shakkeela Padanilathu Kunjummar</dc:creator>
<dc:creator>Bobby Yanagawa</dc:creator>
<dc:creator>Kim A Connelly</dc:creator>
<dc:creator>C David Mazer</dc:creator>
<dc:creator>Ori D Rotstein</dc:creator>
<dc:creator>Adrian Quan</dc:creator>
<dc:creator>Deepak L Bhatt</dc:creator>
<dc:creator>Darren K McGuire</dc:creator>
<dc:creator>David A Hess</dc:creator>
<dc:creator>Subodh Verma</dc:creator>
<dc:date>2024-02-14</dc:date>
<dc:source>Journal of the American College of Cardiology</dc:source>
<dc:title>Vascular Regenerative Cell Deficiencies in South Asian Adults</dc:title>
<dc:identifier>pmid:38355246</dc:identifier>
<dc:identifier>doi:10.1016/j.jacc.2023.12.012</dc:identifier>
</item>
<item>
<title>Getting to the Heart of the Problem in Spinal Cord Injury</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38355245/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240215230943&amp;v=2.18.0
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">J Am Coll Cardiol. 2024 Feb 20;83(7):752-754. doi: 10.1016/j.jacc.2023.12.011.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38355245/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240215230943&v=2.18.0">38355245</a> | DOI:<a href=https://doi.org/10.1016/j.jacc.2023.12.011>10.1016/j.jacc.2023.12.011</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38355245</guid>
<pubDate>Wed, 14 Feb 2024 06:00:00 -0500</pubDate>
<dc:creator>Christopher R West</dc:creator>
<dc:creator>Jacquelyn J Cragg</dc:creator>
<dc:date>2024-02-14</dc:date>
<dc:source>Journal of the American College of Cardiology</dc:source>
<dc:title>Getting to the Heart of the Problem in Spinal Cord Injury</dc:title>
<dc:identifier>pmid:38355245</dc:identifier>
<dc:identifier>doi:10.1016/j.jacc.2023.12.011</dc:identifier>
</item>
<item>
<title>Increased Risk of Myocardial Infarction, Heart Failure, and Atrial Fibrillation After Spinal Cord Injury</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38355244/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240215230943&amp;v=2.18.0
      <description>CONCLUSIONS: SCI survivors at all levels were at significantly greater risk for heart disease than non-SCI controls, particularly those with severe disability. Clinicians must be aware of the importance of heart disease in SCI survivors.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">J Am Coll Cardiol. 2024 Feb 20;83(7):741-751. doi: 10.1016/j.jacc.2023.12.010.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: Heart diseases are a growing concern for the spinal cord injury (SCI) population.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">OBJECTIVES: This study aims to compare the incidence of heart diseases between SCI survivors and the general non-SCI population.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: We identified 5,083 SCI survivors and 1:3 age- and sex-matched non-SCI controls. Study outcomes were myocardial infarction (MI), heart failure (HF), and atrial fibrillation (AF). The cohort was followed up from the index date (diagnosis date for SCI or corresponding date for matched controls) until 2019.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: SCI survivors showed a higher risk for MI (adjusted HR [aHR]: 2.41; 95% CI: 1.93-3.00), HF (aHR: 2.24; 95% CI: 1.95-2.56), and AF (aHR: 1.84; 95% CI: 1.49-2.28) compared to controls. The risks were further increased for those who were registered in the National Disability Registry within 1 year from the index date (SCI survivors with disability): SCI survivors with severe disability had the highest risks of MI (aHR: 3.74; 95% CI: 2.43-5.76), HF (aHR: 3.96; 95% CI: 3.05-5.14), and AF (aHR: 3.32; 95% CI: 2.18-5.05). Cervical and lumbar SCI survivors had an increased risk of heart disease regardless of disability compared to matched controls; these risks were slightly higher in those with disability. Thoracic SCI survivors with disability had significantly increased risk of heart disease compared to matched controls.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: SCI survivors at all levels were at significantly greater risk for heart disease than non-SCI controls, particularly those with severe disability. Clinicians must be aware of the importance of heart disease in SCI survivors.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38355244/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240215230943&v=2.18.0">38355244</a> | DOI:<a href=https://doi.org/10.1016/j.jacc.2023.12.010>10.1016/j.jacc.2023.12.010</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38355244</guid>
<pubDate>Wed, 14 Feb 2024 06:00:00 -0500</pubDate>
<dc:creator>Jung Eun Yoo</dc:creator>
<dc:creator>Miso Kim</dc:creator>
<dc:creator>Bongseong Kim</dc:creator>
<dc:creator>Heesun Lee</dc:creator>
<dc:creator>Won Hyuk Chang</dc:creator>
<dc:creator>Jeehyun Yoo</dc:creator>
<dc:creator>Kyungdo Han</dc:creator>
<dc:creator>Dong Wook Shin</dc:creator>
<dc:date>2024-02-14</dc:date>
<dc:source>Journal of the American College of Cardiology</dc:source>
<dc:title>Increased Risk of Myocardial Infarction, Heart Failure, and Atrial Fibrillation After Spinal Cord Injury</dc:title>
<dc:identifier>pmid:38355244</dc:identifier>
<dc:identifier>doi:10.1016/j.jacc.2023.12.010</dc:identifier>
</item>
<item>
<title>Turning to "Omics" in Understanding Fontan-Associated Liver Disease</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38355243/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240215230943&amp;v=2.18.0
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">J Am Coll Cardiol. 2024 Feb 20;83(7):739-740. doi: 10.1016/j.jacc.2023.12.025.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38355243/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240215230943&v=2.18.0">38355243</a> | DOI:<a href=https://doi.org/10.1016/j.jacc.2023.12.025>10.1016/j.jacc.2023.12.025</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38355243</guid>
<pubDate>Wed, 14 Feb 2024 06:00:00 -0500</pubDate>
<dc:creator>Yuli Y Kim</dc:creator>
<dc:creator>Maarouf A Hoteit</dc:creator>
<dc:date>2024-02-14</dc:date>
<dc:source>Journal of the American College of Cardiology</dc:source>
<dc:title>Turning to "Omics" in Understanding Fontan-Associated Liver Disease</dc:title>
<dc:identifier>pmid:38355243</dc:identifier>
<dc:identifier>doi:10.1016/j.jacc.2023.12.025</dc:identifier>
</item>





























</channel>
</rss>